Surdosages en antivitamine K dans une population de patients hospitalisés âgés de plus de 70 ans : Enquête prospective sur un an = Excess antivitamin K in elderly hospitalised patients aged over 70: A one-year prospectiveSIGURET, V; ESQUIROL, C; DEBRAY, M et al.La Presse médicale (1983). 2003, Vol 32, Num 21, pp 972-977, issn 0755-4982, 6 p.Article

Solving the mystery of excessive warfarin-induced bleeding: A personal historical perspectiveHIRSH, Jack.Thrombosis and haemostasis. 2014, Vol 112, Num 5, pp 853-856, issn 0340-6245, 4 p.Article

Flow injection analysis of warfarin sodium with amperometric detectionFATHALLA BELAL; ANDERSON, J. L.Mikrochimica acta (1966. Print). 1985, Vol 2, Num 3-4, pp 145-151, issn 0026-3672Article

Pour mieux surveiller un traitement anticoagulant par les antivitamines K = For a best control of an anticoagulant treatment with antivitamins KJournal de pharmacie clinique (Paris). 1986, Vol 5, Num 3, pp 341-343, issn 0291-1981Article

Anticoagulants : antivitamines K : principes et règles d'utilisation, posologie = Anticoagulants: antivitamins KMISMETTI, P; DECOUSUS, H.La Revue du praticien (Paris). 1995, Vol 45, Num 8, pp 1014-1017, issn 0035-2640Article

A Bayesian Dose-Individualization Method for WarfarinWRIGHT, Daniel F. B; DUFFULL, Stephen B.Clinical pharmacokinetics. 2013, Vol 52, Num 1, pp 59-68, issn 0312-5963, 10 p.Article

Warfarin-induced skin necrosisMUNGALSINGH, Catherine R; BOMFORD, Jamie; NAYAGAM, Jeremy et al.Clinical medicine. 2012, Vol 12, Num 1, pp 90-91, issn 1470-2118, 2 p.Article

Factor VII Levels and International Normalized Ratios in the Early Phase of Warfarin TherapyBENZON, Honorio T; AVRAM, Michael J; BENZON, Hubert A et al.Anesthesiology (Philadelphia). 2010, Vol 112, Num 2, pp 298-304, issn 0003-3022, 7 p.Article

Provision of warfarin education to hospital inpatientsBAUGHMAN, Christopher; SPURLING, Lisa; MANGONI, Arduino A et al.British journal of clinical pharmacology. 2008, Vol 66, Num 3, pp 416-417, issn 0306-5251, 2 p.Article

The story of the discovery of heparin and warfarinWARDROP, Douglas; KEELING, David.British journal of haematology. 2008, Vol 141, Num 6, pp 757-763, issn 0007-1048, 7 p.Article

Probable Interaction Between Warfarin and TorsemideBIRD, Jennifer; CARMONA, Carlos.The Annals of pharmacotherapy. 2008, Vol 42, Num 12, pp 1893-1898, issn 1060-0280, 6 p.Article

Etude et evaluation cardio-vasculaire avec le Centre National Hospitalier d'Information sur le Médicament: Interactions medicamenteuses avec les antivitamines K = Study and evaluation with the Centre national Hospitalier d'Information sur le Médicament: interactions with antivitamin KEtudes & évaluation cardio-vasculaires. 1999, Vol 6, Num 5, pp 225-228, issn 1251-3571Article

Les antivitamines K: surveillance du traitement et interactions médicamenteuses à bien connaître = Oral anticoagulants: supervision of treatment and drug interactionsLE ROUX, G.Gazette médicale (Paris). 1995, Vol 102, Num 17, pp 8-10, issn 0760-758XArticle

The need for closer control of warfarin therapyWILSON, R. H; MULHOLLAND, C; MACKLE, E. J et al.Journal of the Royal College of Surgeons of Edinburgh. 1994, Vol 39, Num 3, pp 171-173, issn 0035-8835Article

Automated method for the quantitative determination of warfarin sodiumPANUSHEV, A; VELINOV, G; MANOLOV, I et al.Pharmazie. 1992, Vol 47, Num 4, pp 302-303, issn 0031-7144Article

Pour une meilleure appréciation du risque hémorragique à la phase initiale des traitements par antivitamine K = For a better evaluation of the risk of haemorrhage in the initial phase of antivitamin K therapyMASSIGNON, D; DEBIZE, G; COEUR, P et al.La Presse médicale (1983). 1988, Vol 17, Num 2, issn 0755-4982, 78Article

Pour mieux surveiller un traitement anticoagulant par les antivitamines K. Recommandation du groupe d'étude sur l'hémostase et la thrombose = How to better monitor an anticoagulant treatment with anti-vitamin KBONEU, B.Revue française de gynécologie et d'obstétrique. 1987, Vol 82, Num 2, pp 133-134, issn 0035-290XArticle

Importance de la standardisation dans la surveillance biologique des traitements par les anti-vitamines K = Importance of standardisation for biological monitoring of antivitamines-K treatmentsFORESTIER, F; BONEU, B; POTRON, G et al.Nouvelle revue française d'hématologie. 1986, Vol 28, Num 3, pp 157-162, issn 0029-4810Article

New Oral Anticoagulants: Comparative Pharmacology with Vitamin K AntagonistsSCAGLIONE, Francesco.Clinical pharmacokinetics. 2013, Vol 52, Num 2, pp 69-82, issn 0312-5963, 14 p.Article

Genetic, Clinical and Behavioural Determinants of Vitamin K-Antagonist Dose ― Explored Through Multivariable Modelling and VisualizationSKOV, Jane; BLADBJERG, Else-Marie; RASMUSSEN, Morten A et al.Basic & clinical pharmacology & toxicology (Print). 2012, Vol 110, Num 2, pp 193-198, issn 1742-7835, 6 p.Article

Pregnancy outcome after maternal intoxication with phenprocoumonHAUCK, Barbara; ZIMMERMANN, Robert; RINGWALD, Juergen et al.British journal of clinical pharmacology. 2011, Vol 71, Num 1, pp 139-140, issn 0306-5251, 2 p.Article

Cranberry Juice and Warfarin: When Bad Publicity Trumps ScienceZIKRIA, Jennifer; GOLDMAN, Raimonda; ANSELL, Jack et al.The American journal of medicine. 2010, Vol 123, Num 5, pp 384-392, issn 0002-9343, 9 p.Article

Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: PreventionGARCIA, David; AGENO, Walter; SCHULMAN, Sam et al.American journal of hematology. 2009, Vol 84, Num 9, pp 579-583, issn 0361-8609, 5 p.Article

Genetic-based dosing in orthopedic patients beginning warfarin therapy. CommentaryGOLDHABER, Samuel Z; MILLICAN, Eric A; BURNETT, R. Stephen J et al.Blood. 2007, Vol 110, Num 5, issn 0006-4971, 1404-1405, 1511-1515 [7 p.]Article

Vitamin K and maintenance of skeletal integrity in adultsROSEN, H. N; MAITLAND, L. A; SUTTIE, J. W et al.The American journal of medicine. 1993, Vol 94, Num 1, pp 62-68, issn 0002-9343Article